Baltimore startup Vita Therapeutics raises $31M to advance treatment for genetic diseases By: Baltimore Business Journal via Business Journals October 12, 2022 at 13:02 PM EDT The round is part of a wave of activity in the cell therapy industry in Maryland. Read More >> Related Stocks: Harbor Disruptive Innovation ETF
